In response to the Federal Competition Commission’s blocking of Nestle SA’s $11.85 billion buyout of Pfizer Inc.’s infant nutrition business due to competition concerns, Nestle has reportedly agreed to divest Pfizer’s baby formula operations. The CFC originally blocked the deal last November after it found Nestle, which is based in Switzerland, would have too much of a dominant position in the market in Mexico after the acquisition. The competition authority has announced its approval of the concessions. Nestle outbid Groupe Danone SA to buy the Pfizer conglomerate last year.
Featured News
Coinbase Sues Three States Over Prediction Market Regulations
Dec 19, 2025 by
CPI
Walmart and PayPal Execs Say Prompts Could Trigger AI-Driven Coordination
Dec 19, 2025 by
CPI
Trump Signals New Openness to Filling Democratic Seats on SEC, CFTC, Easing Frictions Over Crypto Bill
Dec 19, 2025 by
CPI
Mexico Antitrust Authority Closes Android Competition Case After Google Commitments
Dec 18, 2025 by
CPI
LinkedIn Antitrust Settlement Faces Setback in California Court
Dec 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi